Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 2.3 6.98% 0.15
ACHN closed up 6.98 percent on Thursday, January 17, 2019, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ACHN trend table...

Date Alert Name Type % Chg
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 17 Weak + Overbought Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 Shooting Star Candlestick Bearish 6.98%
Jan 16 Stochastic Sell Signal Bearish 6.98%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.98%
Jan 16 Weak + Overbought Other 6.98%
Jan 16 Wide Bands Range Expansion 6.98%

Older signals for ACHN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company's drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.34
52 Week Low 1.29
Average Volume 2,553,234
200-Day Moving Average 3.0048
50-Day Moving Average 2.4498
20-Day Moving Average 1.787
10-Day Moving Average 2.077
Average True Range 0.1944
ADX 22.82
+DI 28.5195
-DI 19.4135
Chandelier Exit (Long, 3 ATRs ) 2.6068
Chandelier Exit (Short, 3 ATRs ) 1.8732
Upper Bollinger Band 2.4213
Lower Bollinger Band 1.1527
Percent B (%b) 0.9
BandWidth 70.990487
MACD Line -0.0626
MACD Signal Line -0.1627
MACD Histogram 0.1001
Fundamentals Value
Market Cap 314.55 Million
Num Shares 137 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -4.60
Price-to-Sales 33.83
Price-to-Book 1.40
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.75
Resistance 3 (R3) 2.75 2.59 2.68
Resistance 2 (R2) 2.59 2.48 2.60 2.65
Resistance 1 (R1) 2.45 2.41 2.52 2.45 2.62
Pivot Point 2.29 2.29 2.33 2.30 2.29
Support 1 (S1) 2.15 2.18 2.22 2.15 1.98
Support 2 (S2) 1.99 2.11 2.00 1.95
Support 3 (S3) 1.85 1.99 1.93
Support 4 (S4) 1.85